Role of FCI in the Detection of Proctosigmoiditis Caused by IBD (NCT05817266) | Clinical Trial Compass
WithdrawnNot Applicable
Role of FCI in the Detection of Proctosigmoiditis Caused by IBD
Stopped: Funding period ended
United Kingdom0Started 2024-03
Plain-language summary
The goal of this pilot study is to explore the ability of field-cycling imaging, a new scanning technology being developed at the University of Aberdeen, to detect active disease in patients with proctosigmoiditis caused by inflammatory bowel disease.
Who can participate
Age range16 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants with a diagnosis of proctosigmoiditis, on the basis of a compatible history and previous flexible sigmoidoscopy
* Participants who are already under follow up in the NHS Grampian IBD clinic
* Participants must be between 16 and 80 years old
* Participants who meet the safety criteria for undergoing an MRI scan
* Participants who are able to fit inside the scanner
* Participants must be able to give fully informed consent
* Participants must be mobile enough to be positioned onto the FCI scanner couch
Exclusion Criteria:
* MRI-incompatible conditions, as detected in the MRI safety screening sheet
* Participants under 16 years old
* Participants who are unable to communicate in English
* Participants who are unable to give fully informed consent
* Women who are pregnant
* Restrictions to mobility that would prevent the correct positioning in the scanner
* Previous major abdominal surgery
* Any known significant comorbid disease that might interfere with treatment
* Malignancy or other conditions that would significantly reduce life expectancy
* Participants who suffer from claustrophobia
What they're measuring
1
Detection of proctosigmoiditis assessed by field-cycling imaging (FCI) scan